Deep Medicine Acquisition Corp.
DMAQ · NASDAQ
12/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | -$0 |
| Revenue | $0 | $0 | $0 | – |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | -$0 | – |
| % Margin | 66.7% | – | – | – |
| EBITDA | -$0 | -$0 | -$0 | – |
| % Margin | -9.6% | – | – | – |
| Net Income | -$0 | -$0 | -$0 | – |
| % Margin | -40.2% | – | – | – |
| EPS Diluted | -0.76 | -0.04 | -0.041 | – |
| % Growth | -1,800% | 2.4% | – | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | – |
| Capital Expenditures | -$0 | $0 | $0 | – |
| Free Cash Flow | -$0 | -$0 | -$0 | – |